ConductScience.org, home

Paper28323271

A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.

Tu H and 8 others. Am J Gastroenterol, 2017. Cited by 96 papers, by iCite.

Cite this record

ConductScience Library. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Papers, record 28323271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28323271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
PubMed
Journal
Am J Gastroenterol
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
4.34
iCite
Revised in PubMed
2022-04-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tu HHuakang
2Sun LLiping
3Dong XXiao
4Gong YYuehua
5Xu QQian
6Jing JJingjing
7Bostick RMRoberd M
8Wu XXifeng
9Yuan YYuan

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antibodies, BacterialMajor topic
GastrinsMajor topic
Helicobacter pyloriMajor topic
Pepsinogen AMajor topic
Pepsinogen CMajor topic
Precancerous ConditionsMajor topic
Stomach NeoplasmsMajor topic
Adult
Aged
Biomarkers
Biopsy
Cross-Sectional Studies
Female
Follow-Up Studies
Gastric Mucosa
Gastroscopy
Humans
Logistic Models
Male
Middle Aged
Proportional Hazards Models
ROC Curve
Risk Assessment

Source PubMed

Download CSV of topics

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
42923773Biomarkers for risk stratification of malignancy-prone precancerous conditions: focusing on gastric intestinal metaplasia.Med Rev (2021)2026https://conductscience.org/library/papers/42923773PubMed
42226123Divergent roles of endoscopic Kyoto classification and serological Li's scoring in immediate and long-term gastric cancer risk stratification: a 4-year longitudinal study.BMC Gastroenterol2026https://conductscience.org/library/papers/42226123PubMed
41834169The Role of Serum Pepsinogen Tests for Detecting Gastric Cancer Between Sexes and Among Age Groups.Gut Liver2026https://conductscience.org/library/papers/41834169PubMed
41388069Mucin phenotype-based deep learning framework for intestinal metaplasia-carcinogenesis progression prediction.NPJ Precis Oncol2025https://conductscience.org/library/papers/41388069PubMed
41275148Development and validation of a simple prediction risk score for predicting risk of gastric cancer in outpatient department.BMC Cancer2025https://conductscience.org/library/papers/41275148PubMed
40670850Serum TFF2 as a more reliable biomarker for gastric cancer and early gastric cancer: a cross-sectional population-based study.Gastric Cancer2025https://conductscience.org/library/papers/40670850PubMed
40502335Chronic Atrophic Gastritis and Intestinal Metaplasia: A Latin American Perspective.Korean J Helicobacter Up Gastrointest Res2024https://conductscience.org/library/papers/40502335PubMed
40468756Development and Validation of Predictive Models for Gastric Neoplasm Risk Stratification in Screening Esophagogastroduodenoscopy.Gut Liver2025https://conductscience.org/library/papers/40468756PubMed
40353072Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions.Chin J Cancer Res2025https://conductscience.org/library/papers/40353072PubMed
40211909A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels.Gut Liver2025https://conductscience.org/library/papers/40211909PubMed
40012220Vitamin C Mediates IGFBP7 to Alleviate Chronic Atrophic Gastritis via the HIF-1α/VEGF Pathway.J Cell Mol Med2025https://conductscience.org/library/papers/40012220PubMed
39941460Point-of-Care Diagnosis of Atrophic Gastritis by Serological Biomarker Test (GastroPanel® Quick Test) in Gastroscopy Referral Patients in India.J Clin Med2025https://conductscience.org/library/papers/39941460PubMed
39678515Establishment and validation of a nomogram model for early diagnosis of gastric cancer: a large-scale cohort study.Front Oncol2024https://conductscience.org/library/papers/39678515PubMed
39509055Racial/ethnic differences in risk factors for non-cardia gastric cancer: an analysis of the Multiethnic Cohort (MEC) Study.Cancer Causes Control2025https://conductscience.org/library/papers/39509055PubMed
39440067Comparing Participation and Interim Effectiveness of Endoscopy and Biomarker-Based Screening for Gastric Cancer: A Cluster Randomized Controlled Trial.J Cancer2024https://conductscience.org/library/papers/39440067PubMed
39377973Development and validation of a relatively accurate gastric cancer high-risk group screening scoring system in urban residents.Clin Transl Oncol2025https://conductscience.org/library/papers/39377973PubMed
39317493Investigations and referral for suspected gastric cancer by primary care physicians: a cross-sectional study in Southeastern China.BMJ Open2024https://conductscience.org/library/papers/39317493PubMed
39257385Risk Prediction Models for Gastric Cancer: A Scoping Review.J Multidiscip Healthc2024https://conductscience.org/library/papers/39257385PubMed
38791874Pepsinogen C Interacts with IQGAP1 to Inhibit the Metastasis of Gastric Cancer Cells by Suppressing Rho-GTPase Pathway.Cancers (Basel)2024https://conductscience.org/library/papers/38791874PubMed
38764808Hotspots and trends of risk factors in gastric cancer: A visualization and bibliometric analysis.World J Gastrointest Oncol2024https://conductscience.org/library/papers/38764808PubMed

See all 70 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BGN633PubTator's text mininghttps://conductscience.org/library/genes/633NCBI Gene
PGC5225PubTator's text mininghttps://conductscience.org/library/genes/5225NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28323271

GET https://conductscience.org/api/papers/v1/28323271/cited_by?page=2